Company / R&D Expense
Neuraxis, INC R&D Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$493.6K
FY2025
5-year range
$169.3K / $493.6K
FY2023-FY2025
Trend
+191.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $225,610 to $493,611 over the past 2 years.
Based on SEC 10-K filings.
$493,611 in FY2025.
Improved from $225,610 to $493,611 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d expense increased 191.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $493.6K | +191.5% |
| FY2024 | $169.3K | -25.0% |
| FY2023 | $225.6K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026